Evidence map›Paper›PMID 26274324›Full record

ArticlePloS one2015

Spatial and Temporal Control of Cavitation Allows High In Vitro Transfection Efficiency in the Absence of Transfection Reagents or Contrast Agents.

Kamel Chettab, Stéphanie Roux, Doriane Mathé, Emeline Cros-Perrial, Maxime Lafond, Cyril Lafon, Charles Dumontet, Jean-Louis Mestas

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kamel ChettabUniversité de Lyon, 69000, Lyon, France; Université de Lyon 1, 69000, Lyon, France; INSERM U1052, Centre de Recherche en Cancérologie de Lyon, 69008, Lyon, France; CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, 69008, Lyon, France; Caviskills SAS, Vaulx-en-Velin, France.
Stéphanie RouxUniversité de Lyon, 69000, Lyon, France; Université de Lyon 1, 69000, Lyon, France; INSERM U1052, Centre de Recherche en Cancérologie de Lyon, 69008, Lyon, France; CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, 69008, Lyon, France.
Doriane MathéUniversité de Lyon, 69000, Lyon, France; Université de Lyon 1, 69000, Lyon, France; INSERM U1052, Centre de Recherche en Cancérologie de Lyon, 69008, Lyon, France; CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, 69008, Lyon, France.
Emeline Cros-PerrialUniversité de Lyon, 69000, Lyon, France; Université de Lyon 1, 69000, Lyon, France; INSERM U1052, Centre de Recherche en Cancérologie de Lyon, 69008, Lyon, France; CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, 69008, Lyon, France.
Maxime LafondUniversité de Lyon, 69000, Lyon, France; Université de Lyon 1, 69000, Lyon, France; Inserm, U1032, LabTau, Lyon, F-69003, France.
Cyril LafonUniversité de Lyon, 69000, Lyon, France; Université de Lyon 1, 69000, Lyon, France; Caviskills SAS, Vaulx-en-Velin, France; Inserm, U1032, LabTau, Lyon, F-69003, France.
Charles DumontetUniversité de Lyon, 69000, Lyon, France; Université de Lyon 1, 69000, Lyon, France; INSERM U1052, Centre de Recherche en Cancérologie de Lyon, 69008, Lyon, France; CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, 69008, Lyon, France.
Jean-Louis MestasUniversité de Lyon, 69000, Lyon, France; Université de Lyon 1, 69000, Lyon, France; Caviskills SAS, Vaulx-en-Velin, France; Inserm, U1032, LabTau, Lyon, F-69003, France.
Inserm · FRUniversité Claude Bernard Lyon 1 · FRSolvay (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sonoporation using low-frequency high-pressure ultrasound (US) is a non-viral approach for in vitro and in vivo gene delivery. In this study, we developed a new sonoporation device designed for spatial and temporal control of ultrasound cavitation. The regulation system incorporated in the device allowed a real-time control of the cavitation level during sonoporation. This device was evaluated for the in vitro transfection efficiency of a plasmid coding for Green Fluorescent Protein (pEGFP-C1) in adherent and non-adherent cell lines. The transfection efficiency of the device was compared to those observed with lipofection and nucleofection methods. In both adherent and non-adherent cell lines, the sonoporation device allowed high rate of transfection of pEGFP-C1 (40-80%), as determined by flow cytometry analysis of GFP expression, along with a low rate of mortality assessed by propidium iodide staining. The transfection efficiency and toxicity of sonoporation on the non-adherent cell lines Jurkat and K562 were similar to those of nucleofection, while these two cell lines were resistant to transfection by lipofection. Moreover, sonoporation was used to produce three stably transfected human lymphoma and leukemia lines. Significant transfection efficiency was also observed in two fresh samples of human acute myeloid leukemia cells. In conclusion, we developed a user-friendly and cost-effective ultrasound device, well adapted for routine in vitro high-yield transfection experiments and which does not require the use of any transfection reagent or gas micro-bubbles.

Indexed as

Cell Line, TumorCell SurvivalGene Transfer TechniquesHL-60 CellsHumansIn Vitro TechniquesJurkat CellsLeukemiaLymphomaSonicationTransfectionUltrasonicsUltrasonography

Identifiers

PMID26274324
PMCPMC4537239
OpenAlexW1750790106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.